CYTK
Cytokinetics Incorporated
Company Overview
| Mkt Cap | $5.82B | Price | $63.59 |
| Volume | 2.43M | Change | +2.15% |
| P/E Ratio | -9.9 | Open | $63.14 |
| Revenue | $18.5M | Prev Close | $62.25 |
| Net Income | $-589.5M | 52W Range | $29.31 - $64.13 |
| Div Yield | N/A | Target | $76.26 |
| Overall | 59 | Value | 40 |
| Quality | 47 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyCytokinetics Incorporated (CYTK) is a leading Healthcare company in the Biotechnology industry, currently trading at $63.59 with a market capitalization of $5.82 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 47.
Today's trading session shows CYTK with a volume of 2.43 million shares. The stock opened up 1.43% from yesterday's close of $62.25. Current analyst estimates project earnings of $-5.65 per share for this year, with next year targeting $-5.83.
CYTK demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ABIO, LGND, ACOR, TRVN, AMGN.
Key investment considerations for CYTK include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 19.9%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:11 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYTK | $63.59 | +2.2% | 2.43M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cytokinetics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW